Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-83,689
Closed -$2.32M 126
2014
Q3
$2.32M Buy
83,689
+652
+0.8% +$18.3K 2.28% 10
2014
Q2
$2.4M Buy
+83,037
New +$2.37M 2.37% 10

Other funds holding PFE

L.J. Altfest & Co's PFE Position: Q2 2026 in Review

L.J. Altfest & Co increased its Pfizer (PFE) stake by 9.7% in Q2 2026, buying an estimated $83.4K and bringing the position to 36,216 shares worth $872K. The position accounts for 0.08% of the portfolio, ranked #148.

L.J. Altfest & Co first reported a position in PFE in Q4 2013 and has held it in 48 quarters since. The position peaked at $3.77M in Q3 2017. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • L.J. Altfest & Co held 36,216 shares of Pfizer worth $872K as of Q2 2026.
  • L.J. Altfest & Co bought 3,188 Pfizer shares in Q2 2026, an estimated $83.4K.
  • Pfizer made up 0.08% of L.J. Altfest & Co's portfolio in Q2 2026, its #148 holding.
  • L.J. Altfest & Co first reported a position in Pfizer in Q4 2013 and has held it in 48 quarters since.
  • L.J. Altfest & Co's Pfizer position peaked at $3.77M in Q3 2017.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on L.J. Altfest & Co's 13F filing for Q2 2026, filed 30 Jul 2026.